Potassium repletion is common in patients hospitalized with heart failure exacerbations; however, the evidence for this practice is lacking. In a subset of patients hospitalized with acute heart ...
AUSTIN, Texas, Oct. 31, 2025 /PRNewswire/ -- Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The ...
AUBURN, Ala. & TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback